Drug Type Small molecule drug |
Synonyms TH1027 |
Target |
Action antagonists |
Mechanism TLR8 antagonists(Toll like receptor 8 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Preclinical | Japan | 23 Apr 2020 | |
| Inflammation | Preclinical | Japan | 23 Apr 2020 |





